What happens to the bone structure after normocalcemic primary hyperparathyroidism surgery?

被引:8
|
作者
Osorio-Silla, Irene [1 ]
Gomez-Ramirez, Joaquin [2 ]
Valdazo-Gomez, Adela [3 ]
Salido Fernandez, Sergio [1 ]
Sanchez Garcia, Carmen [1 ]
Pardo Garcia, Ricardo [1 ]
机构
[1] Univ Hosp Fdn Jimenez Diaz, Dept Surg, Madrid, Spain
[2] Univ Hosp Ramon Y Cajal, Dept Surg, Madrid, Spain
[3] Univ Hosp Infanta Leonor, Dept Surg, Madrid, Spain
关键词
MINERAL DENSITY; TURNOVER MARKERS; PARATHYROIDECTOMY; OUTCOMES;
D O I
10.1016/j.surg.2021.08.047
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Bone disease in primary hyperparathyroidism is a clear indication for surgical treatment. However, it is not known whether surgery benefits hypercalcemic primary hyperparathyroidism and normocalcemic primary hyperparathyroidism equally. The aim of our study was to evaluate the bone changes in patients undergoing parathyroidectomy based on the biochemical profile 1 and 2 years after surgery. Methods: This prospective study included 87 consecutive patients diagnosed with primary hyperparathyroidism who underwent surgery between 2016 and 2018. Bone densitometry (1/3 distal radius, lumbar, and femur) and bone remodeling markers (osteocalcin, type 1 procollagen [P1NP], beta-cross-linked telopeptide of type I collagen [BCTX]) were performed preoperatively and postoperatively. Postoperative changes in bone mineral density and bone markers were compared and evaluated according to the clinical characteristics and the individual biochemical profile. Results: One year after surgery, all patients showed an increase in bone mineral density at the lumbar site (mean, 0.029 g/cm(2); range, 0.017-0.04; P < .001) and femur neck (mean, 0.025 g/cm(2); range, 0.002-0.05; P < .001); however, there were no changes in the distal third of the radius (mean, -0.003 g/cm(2); range, -0.008 to 0.002; P = NS). There were no significant differences when comparing normocalcemic primary hyperparathyroidism and hypercalcemic primary hyperparathyroidism. Serum osteocalcin (37 +/- 17.41), P1NP (67.53 +/- 31.81) and BCTX (0.64 +/- 0.37) levels were elevated before surgery. One year after the surgery, we observed a significant decrease in P1NP (33.05 +/- 13.16, P = .001), osteocalcin (15.80 +/- 6.19, P = .001), and BCTX (0.26 +/- 0.32, P < .001) levels. . Conclusion: Our findings indicate that parathyroidectomy has similar benefits for normocalcemic primary hyperparathyroidism and hypercalcemic primary hyperparathyroidism in terms of bone improvement. Although the most substantial improvement occurred during the first postoperative year in both groups, we consider that studies with longer follow-up are warranted. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:932 / 939
页数:8
相关论文
共 50 条
  • [31] Challenges in Diagnosing of Normocalcemic Primary Hyperparathyroidism
    Pepe, Jessica
    Sonato, Chiara
    Colangelo, Luciano
    Minisola, Salvatore
    Cipriani, Cristiana
    ENDOCRINE PRACTICE, 2021, 27 (06) : 644 - 644
  • [32] NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM WITH OSTEITIS FIBROSA
    FRAME, B
    FOROOZANFAR, F
    PATTON, RB
    ANNALS OF INTERNAL MEDICINE, 1970, 73 (02) : 253 - +
  • [33] A practical approach to normocalcemic primary hyperparathyroidism
    Munoz de Nova, Jose Luis
    Sampedro-Nunez, Miguel
    Huguet-Moreno, Isabel
    Marazuela Azpiroz, Monica
    ENDOCRINE, 2021, 74 (02) : 235 - 244
  • [34] Normocalcemic primary hyperparathyroidism: a growing problem
    Martinez Diaz-Guerra, Guillermo
    Guadalix Iglesias, Sonsoles
    Hawkins Carranza, Federico
    MEDICINA CLINICA, 2013, 141 (03): : 125 - 129
  • [35] Approach to the Patient: Normocalcemic Primary Hyperparathyroidism
    Liu, Yi
    Gregory, Naina Sinha
    Andreopoulou, Panagiota
    Kashyap, Sangeeta
    Cusano, Natalie
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [36] NORMOCALCEMIC (MASKED) PRIMARY (OR TERTIARY) HYPERPARATHYROIDISM
    DENT, CE
    SOUTH AFRICAN MEDICAL JOURNAL, 1975, 49 (13): : 476 - 476
  • [37] Surgical Management of Normocalcemic Primary Hyperparathyroidism
    Thomas J. Wade
    Tina W. F. Yen
    Amanda L. Amin
    Tracy S. Wang
    World Journal of Surgery, 2012, 36 : 761 - 766
  • [38] Surgical Management of Normocalcemic Primary Hyperparathyroidism
    Wade, Thomas J.
    Yen, Tina W. F.
    Amin, Amanda L.
    Wang, Tracy S.
    WORLD JOURNAL OF SURGERY, 2012, 36 (04) : 761 - 766
  • [39] Bone Metabolism in Patients with Primary Hyperparathyroidism Before and After Surgery
    Kerschan-Schindl, K.
    Riss, P.
    Krestan, C.
    Rauner, M.
    Bieglmayer, C.
    Gleiss, A.
    Fialka-Moser, V.
    Niederle, B.
    Pietschmann, P.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (06) : 476 - 481
  • [40] CHANGES IN BONE MASS AND METABOLISM AFTER SURGERY FOR PRIMARY HYPERPARATHYROIDISM
    GARTON, M
    MARTIN, J
    STEWART, A
    KRUKOWSKI, Z
    MATHESON, N
    ROBINS, S
    LOVERIDGE, N
    REID, D
    CLINICAL ENDOCRINOLOGY, 1995, 42 (05) : 493 - 500